Removal of Uremic Toxins With Nocturnal Dialysis Versus Standard Dialysis
1 other identifier
interventional
15
1 country
1
Brief Summary
Dialysis patients, who decide to switch from standard dialysis (3 times 240-270 min/week) to nocturnal dialysis (3 times 480 min/week), will be followed. In parallel a control group with patients staying on standard dialysis will be followed. The study will last 30 weeks. During this period blood samples (pre- and post-dialysis: 10 times; inlet and outlet of dialyzer: 3 times) will be collected on predetermined time points. Concentration of several uremic retention solutes will be determined.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Dec 2005
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2008
CompletedFirst Submitted
Initial submission to the registry
October 3, 2008
CompletedFirst Posted
Study publicly available on registry
October 6, 2008
CompletedOctober 31, 2008
October 1, 2008
2.6 years
October 3, 2008
October 30, 2008
Conditions
Outcome Measures
Primary Outcomes (1)
To evaluate what is more effective for removal of uremic toxins - nocturnal versus standard dialysis?
30 weeks
Study Arms (2)
1
EXPERIMENTALNocturnal dialysis
2
ACTIVE COMPARATORStandard dialysis
Interventions
Eligibility Criteria
You may qualify if:
- age \> 18 years
You may not qualify if:
- pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospital Ghent
Ghent, 9000, Belgium
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Raymond Vanholder, MD, PhD
University Hospital, Ghent
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
October 3, 2008
First Posted
October 6, 2008
Study Start
December 1, 2005
Primary Completion
July 1, 2008
Study Completion
July 1, 2008
Last Updated
October 31, 2008
Record last verified: 2008-10